Clinical Trial Update: Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Completed regulatory post-marketing commitment study for etanercept (Enbrel) with results posted. Sponsor Pfizer reports the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2017-02-23